Film-Spotting chiral miniPEG-γPNA array for BRCA1 gene mutation detection.
BRCA1 mutation
Chiral γPNA
PNA array
Peptide nucleic acid
miniPEG
Journal
Biosensors & bioelectronics
ISSN: 1873-4235
Titre abrégé: Biosens Bioelectron
Pays: England
ID NLM: 9001289
Informations de publication
Date de publication:
01 Jul 2019
01 Jul 2019
Historique:
received:
08
02
2019
revised:
01
04
2019
accepted:
14
04
2019
pubmed:
27
4
2019
medline:
18
10
2019
entrez:
27
4
2019
Statut:
ppublish
Résumé
Peptide nucleic acids array technology is a method of greatly increasing the throughput of laboratory processes to efficiently perform large-scale genetic tests. Diethylene glycol-containing chiral γPNA (miniPEG-γPNA) is considered to be the best PNA derivative and one of the best candidates for gene detection, because it can hybridize DNA with greater affinity and sequence selectivity than DNA and ordinary aminoethylglycyl PNA (aegPNA). Herein, miniPEG-γPNA probes are synthesized by 9-fluorenylmethyloxycarbonyl (Fmoc) solid phase peptide synthesis (SPPS) in a mild condition, and a new biochip fabrication method "Film-Spotting" is invented, by which γPNA arrays with regular pattern, uniform luminance, and very low fluorescence background are obtained easily and cheaply. The miniPEG-γPNA array can effectively distinguish the full matched and mismatched targets in SSarc buffer, serum and urine, and the detection limit of complementary DNA is less than 5.97 nM. A miniPEG-γPNA array for BRCA1 gene mutation (3099delT) detection is also fabricated with a very good detection performance. This work provides an effective avenue for the diagnosis of breast cancer biomarker and expands the application of miniPEG-γPNA in the field of biochip.
Identifiants
pubmed: 31026759
pii: S0956-5663(19)30318-5
doi: 10.1016/j.bios.2019.04.027
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Peptide Nucleic Acids
0
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-7Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.